secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001682852-25-000036
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Moderna shareholders re-elect board, approve executive compensation, ratify auditor
--------------------------------------------------------------------------------

- Class I directors re-elected: Bancel 245.5M for (5.2M against); Afeyan 218.6M for (32.1M against); Nader 195.4M for (55.2M against).
- Advisory 'say-on-pay' passed with 192.3M for, 56.5M against, 43.3M broker non-votes.
- Ratification of Ernst & Young as auditor for FY2025 approved with 290.7M for, 3.2M against.
- Broker non-votes of 43.3M were present on all director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285225000036/0001682852-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285225000036/mrna-20250430.htm
  HTML page:      https://secwatch.observer/filing/0001682852-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer